Romaco to sell Zanchetta business unit

Published: 13-Apr-2007
Media Manufacturing Packaging

Romaco is to sell its Zanchetta business unit, based in Lucca, Italy, to VIMA Impianti, a wholly-owned subsidiary of Italian group IMA.


Romaco is to sell its Zanchetta business unit, based in Lucca, Italy, to VIMA Impianti, a wholly-owned subsidiary of Italian group IMA.

Zanchetta manufactures processing and handling equipment for pharmaceutical solids and powders and achieved net sales of Euro 10m in 2006.

'Over the past two years the Romaco team has worked hard to transform its business to deliver the flexibility, efficiency and competitiveness that are prerequisite for success in the globalised industries we serve,' said Tom Luken, who joined Romaco as president in June 2006.

'We have divested business units that do not align with Romaco's core competences, completely re-engineered our channels to market and have achieved efficient critical mass across our manufacturing operations, where significant investments continue to be made,' he added.

'Concluding the sale of Zanchetta means that Romaco is a much more transparent and focused business with a clear product offering of primary and secondary packaging equipment for the pharmaceutical sector and semi-solids processing equipment for the food and healthcare industries.'

See more

You may also like

You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

How CDMOs can set a new gold standard when it comes to going green

Read more
Sustainability is more than a feel-good initiative or a choice; it’s a strategic imperative. Not missing a beat, pharma companies have been making a concerted effort towards positive change, reports Tim Lowery, President of JSR Life Sciences and CEO, KBI Biopharma

Trending Articles

  1. You need to be a subscriber to read this article.
    Click here to find out more.
    How CDMOs can set a new gold standard when it comes to going green Sustainability is more than a feel-good initiative or a choice; it’s a strategic imperative. Not missing a beat, pharma companies have been making a concerted effort towards positive change, reports Tim Lowery, President of JSR Life Sciences and CEO, KBI Biopharma
  2. Mastering modified-release performance: excipient considerations Imagine a world where enhanced therapeutic efficacy, improved patient compliance and reduced adverse effects are tangible outcomes — even for drugs with short pharmacokinetic (PK) half-lives or narrow therapeutic indices. This is becoming a reality with modified-release (MR) oral delivery systems such as hydrophilic matrix tablets
  3. Get ahead in the pharmaceutical industry with a Manufacturing Chemist subscription With a Manufacturing Chemist subscription you receive exclusive access to the latest news, technical insights, regulatory updates, and market intelligence
  4. Causes and solutions for dark spots in tablet manufacturing Natoli Engineering examines the causes and solutions for dark spots that can halt production
  5. ACG expands global footprint with new capsule manufacturing facility in Thailand New capsule manufacturing facility in Rayong, Thailand, is strategically positioned to serve key Asian markets

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

You may also like

You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

How CDMOs can set a new gold standard when it comes to going green

Sustainability is more than a feel-good initiative or a choice; it’s a strategic imperative. Not missing a beat, pharma companies have been making a concerted effort towards positive change, reports Tim Lowery, President of JSR Life Sciences and CEO, KBI Biopharma
Manufacturing

ACG expands global footprint with new capsule manufacturing facility in Thailand

New capsule manufacturing facility in Rayong, Thailand, is strategically positioned to serve key Asian markets
Manufacturing

Scinai Immunotherapeutics establishes Delaware-based US CDMO subsidiary

The biopharmaceutical company now operates contract development and manufacturing services in both Jerusalem and Delaware
Manufacturing

£20m Scottish oligonucleotide manufacturing innovation centre now under construction

The centre will act as an innovation centre, assisting in the development and optimisation of oligonucleotide manufacturing processes, while also bolstering the UK's biopharmaceutical presence
Manufacturing

Supporting accurate high-pressure flow measurement with Titan's Oval Gear liquid flow meters

The Oval Gear liquid flow meter is built to perform in extreme conditions, and can be customised to a range of industries, including aerospace, mining, marine, automotive and oil & gas
Manufacturing

Precise and efficient VARIO diaphragm pumps from Vacuubrand

Advanced vacuum control for reproducible processes
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

Why quality control should be intimately combined with sterile product development, manufacturing and the overall product supply chain

With sponsor companies increasingly needing to create and launch differentiated, stable, usable and safe injectable treatments for patients, experts at ten23 health are keen to promote the importance of integrating development and/or manufacturing with quality control services
Subscribe now